F. Eichler, Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy, N. Engl. J. Med, vol.377, pp.1630-1638, 2017.

S. Hacein-bey-abina, A modified gamma-retrovirus vector for X-linked severe combined immunodeficiency, N. Engl. J. Med, vol.371, pp.1407-1417, 2014.

S. J. Schuster, Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas, The New England journal of medicine, 2017.

C. A. Herberts, M. S. Kwa, and H. P. Hermsen, Risk factors in the development of stem cell therapy, J. Transl. Med, vol.9, 2011.

A. M. Maguire, Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial, Lancet, vol.374, pp.61836-61841, 2009.

S. Rangarajan, AAV5-Factor VIII Gene Transfer in Severe Hemophilia A. The New England journal of medicine, 2017.

L. A. George, Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant, N. Engl. J. Med, vol.377, pp.2215-2227, 2017.

J. R. Mendell, Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy, N. Engl. J. Med, vol.377, pp.1713-1722, 2017.

E. Smalley and A. A. First, gene therapy poised for landmark approval, Nat. Biotechnol, vol.35, pp.998-999, 2017.

A. F. Tarantal, C. C. Lee, M. L. Martinez, A. Asokan, and R. J. Samulski, Systemic and Persistent Muscle Gene Expression in Rhesus Monkeys with a Liver De-Targeted Adeno-Associated Virus Vector. Hum. gene Ther, vol.28, pp.385-391, 2017.

S. Bortolanza, AAV6-mediated systemic shRNA delivery reverses disease in a mouse model of facioscapulohumeral muscular dystrophy, Mol. Ther, vol.19, pp.2055-2064, 2011.

A. Watakabe, Comparative analyses of adeno-associated viral vector serotypes 1, 2, 5, 8 and 9 in marmoset, mouse and macaque cerebral cortex, Neurosci. Res, vol.93, pp.144-157, 2015.

S. Li, Efficient and Targeted Transduction of Nonhuman Primate Liver With Systemically Delivered Optimized AAV3B Vectors, Mol. Ther, vol.23, pp.1867-1876, 2015.

D. Huser, High Prevalence of Infectious Adeno-associated Virus (AAV) in Human Peripheral Blood Mononuclear Cells Indicative of T Lymphocytes as Sites of AAV Persistence, Journal of virology, vol.91, p.4544, 2017.

A. Meliani, Enhanced liver gene transfer and evasion of preexisting humoral immunity with exosome-enveloped AAV vectors, Blood Adv, vol.1, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02377508

E. Hudry, Exosome-associated AAV vector as a robust and convenient neuroscience tool, Gene Ther, vol.23, pp.380-392, 2016.

S. J. Wassmer, L. S. Carvalho, B. Gyorgy, L. H. Vandenberghe, and C. A. Maguire, Exosome-associated AAV2 vector mediates robust gene delivery into the murine retina upon intravitreal injection, Sci. Rep, vol.7, 2017.

B. Gyorgy, Z. Fitzpatrick, M. H. Crommentuijn, D. Mu, and C. A. Maguire, Naturally enveloped AAV vectors for shielding neutralizing antibodies and robust gene delivery in vivo, Biomater, vol.35, pp.7598-7609, 2014.

B. Gyorgy, Rescue of Hearing by Gene Delivery to Inner-Ear Hair Cells Using Exosome-Associated AAV, Mol. Ther, vol.25, pp.379-391, 2017.

B. Gyorgy and C. A. Maguire, Extracellular vesicles: nature's nanoparticles for improving gene transfer with adeno-associated virus vectors. Wiley interdisciplinary reviews, Nanomedicine and nanobiotechnology, 2017.

C. A. Maguire, Microvesicle-associated AAV vector as a novel gene delivery system, Mol. Ther, vol.20, pp.960-971, 2012.

A. C. Nathwani, Long-term safety and efficacy of factor IX gene therapy in hemophilia B, N. Engl. J. Med, vol.371, 1994.

J. Xie, MicroRNA-regulated, systemically delivered rAAV9: a step closer to CNS-restricted transgene expression, Mol. Ther, vol.19, pp.526-535, 2011.

D. Xu and C. M. Walker, Continuous CD8(+) T-cell priming by dendritic cell cross-presentation of persistent antigen following adeno-associated virus-mediated gene delivery, J. virology, vol.85, pp.12083-12086, 2011.

S. S. Ahmed, A single intravenous rAAV injection as late as P20 achieves efficacious and sustained CNS Gene therapy in Canavan mice, Mol. Ther, vol.21, pp.2136-2147, 2013.

G. Marodon, Specific transgene expression in human and mouse CD4+ cells using lentiviral vectors with regulatory sequences from the CD4 gene, Blood, vol.101, pp.3416-3423, 2003.

D. M. Mccarty, S. M. Young, and R. J. Samulski, Integration of adeno-associated virus (AAV) and recombinant AAV vectors, Annu. Rev. Genet, vol.38, pp.819-845, 2004.

D. W. Russell, A. D. Miller, and I. E. Alexander, Adeno-associated virus vectors preferentially transduce cells in S phase, Proc. Natl Acad. Sci. U S Am, vol.91, pp.8915-8919, 1994.

M. Penaud-budloo, Adeno-associated virus vector genomes persist as episomal chromatin in primate muscle, J. Virol, vol.82, pp.7875-7885, 2008.

J. F. Lang, S. A. Toulmin, K. L. Brida, L. C. Eisenlohr, and B. L. Davidson, Standard screening methods underreport AAV-mediated transduction and gene editing, Nat. Commun, vol.10, 2019.

R. C. Munch, Off-target-free gene delivery by affinity-purified receptor-targeted viral vectors, Nat. Commun, vol.6, 2015.

A. Moreau, Efficient intrathymic gene transfer following in situ administration of a rAAV serotype 8 vector in mice and nonhuman primates, Mol. Ther, vol.17, pp.472-479, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00420211

H. Chono, Optimization of lentiviral vector transduction into peripheral blood mononuclear cells in combination with the fibronectin fragment CH-296 stimulation, J. Biochem, vol.149, pp.285-292, 2011.

A. Pfeiffer, In vivo generation of human CD19-CAR T cells results in B-cell depletion and signs of cytokine release syndrome, EMBO Mol Med, vol.10, 2018.

Q. Zhou, Exclusive Transduction of Human CD4+ T Cells upon Systemic Delivery of CD4-Targeted Lentiviral Vectors, J. Immunol, vol.195, pp.2493-2501, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01911053

A. Jamali, Highly Efficient and Selective CAR-Gene Transfer Using CD4-and CD8-Targeted Lentiviral Vectors, Mol. Ther. Methods Clin. Dev, vol.13, pp.371-379, 2019.

H. Nakai, Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo, J. virology, vol.75, pp.6969-6976, 2001.

P. Hadaczek, H. Mirek, M. S. Berger, and K. Bankiewicz, Limited efficacy of gene transfer in herpes simplex virus-thymidine kinase/ ganciclovir gene therapy for brain tumors, J. Neurosurg, vol.102, pp.328-335, 2005.

A. M. Frank and C. J. Buchholz, Surface-Engineered Lentiviral Vectors for Selective Gene Transfer into Subtypes of Lymphocytes, Mol. Ther. Methods Clin. Dev, vol.12, pp.19-31, 2019.

J. Bennett, AAV2 gene therapy readministration in three adults with congenital blindness, Sci. Transl, 2012.